Medicine & Life Sciences
Genetic Therapy
100%
Mucopolysaccharidosis I
82%
Dependovirus
57%
Intellectual Disability
36%
Mucopolysaccharidosis II
32%
Hematopoietic Stem Cells
31%
Hyperammonemia
28%
Spinocerebellar Ataxias
25%
Beauty
23%
Investigational Therapies
21%
Iduronidase
20%
Ornithine Carbamoyltransferase Deficiency Disease
20%
Mucopolysaccharidoses
17%
Ammonia
16%
Genes
16%
Carbamoyl-Phosphate Synthase I Deficiency Disease
14%
Brain Diseases
11%
Brain
11%
Carbamyl Phosphate
11%
Gene Expression
10%
Lymphocytes
10%
Bacteria
9%
Developmental Disabilities
9%
Human Genetics
8%
Animals
8%
Phenylketonurias
8%
Mammalian Chromosomes
8%
Organized Financing
8%
Cryopreservation
8%
Ligases
7%
Liver Failure
7%
Retroviridae
7%
Intraventricular Infusions
7%
Mutation
7%
Therapeutics
7%
Virus Integration
7%
Bone Marrow Transplantation
7%
Fetal Blood
7%
Blood-Brain Barrier
7%
Enzymes
6%
Cerebellar Ataxia
6%
Veterinary Medicine
6%
Cell- and Tissue-Based Therapy
6%
Dialysis
6%
Nervous System
5%
Bone Marrow
5%
Escherichia coli
5%